Mid-Cap
Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans
Company advances C. difficile treatment program toward Phase 3 international studies Acurx Pharmaceuticals (ACXP) saw its shares move higher after...
ATPC Expands Global Energy Ambitions Through Strategic Partnership with Citadel Investment
Collaboration targets international oil, gas, and petrochemical trading opportunities AGAPE ATP Corporation (ATPC), through its subsidiary ATPC Green Energy Sdn....
Enovix Advances Toward Smartphone Commercialization as Revenue and Margins Improve
Silicon-anode battery developer reports record sales, manufacturing progress, and $621 million liquidity cushion Enovix Corporation (ENVX) reported fourth-quarter and full-year...
Lucid Reports Mixed Q4 Results as Gravity SUV Ramp Pressures Margins
EV maker posts strong revenue growth, wider losses, and upbeat 2026 production outlook Lucid Group reported mixed fourth-quarter results, with...
Hapag-Lloyd to Acquire ZIM in $4.2 Billion Deal, Expanding Global Shipping Power
Acquisition strengthens market position and signals consolidation amid declining freight rates German shipping giant Hapag-Lloyd has agreed to acquire Israeli...
Streamex Corp (STEX): Positioned at the Intersection of Gold and Blockchain Innovation
Tokenization leader strengthens financial flexibility while navigating market pressure and short activity Streamex Corp (STEX) is emerging as a notable...
Rivian Beats Expectations, Targets Major Delivery Growth With Launch of R2 SUV
Electric vehicle maker shows financial progress but warns losses will continue during next phase of expansion Rivian Automotive (RIVN) delivered...
FDA Approves Novocure’s Optune Pax®, Marking Major Breakthrough in Pancreatic Cancer Treatment
First new therapy in nearly 30 years delivers survival benefit using innovative electric field technology The U.S. Food and Drug...
Viking Therapeutics Moves Oral Obesity Drug Into Late-Stage Development
Company advances VKTX program as competition intensifies in the rapidly expanding weight-loss market Viking Therapeutics (VKTX) announced Wednesday that it...
Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery
If demand stabilizes, cost savings stick, and digital/aligners re-accelerate, XRAY could re-rate sharply Dentsply Sirona (XRAY) has been treated like...
